Web Results

en.wikipedia.org/wiki/GenSpera

Inspyr Therapeutics, Inc. (OTC: NSPX) is a development-stage pharmaceutical company based in San Antonio, Texas. The company is focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature. The company's prodrug technology renders the drug ...

www.inspyrtx.com

Inspyr Therapeutics, Inc. Home · About · Technology · Our Prodrugs · Targeting · Oncology · Product Pipeline · News · Press Releases · Presentations · Publications · Videos · In The News · References · Investors · Overview · News / Events · Company Information · Financial Information · Stock Data · SEC Filings · Corporate ...

www.inspyrtx.com/news/press-releases/detail/620/genspera-announces-name-change-to-inspyr-therapeutics

Aug 1, 2016 ... GenSpera Announces Name Change to Inspyr Therapeutics. SAN ANTONIO--( BUSINESS WIRE)-- GenSpera, Inc. ( OTC/QB: GNSZ), ...

www.linkedin.com/company/genspera-inc-

Learn about working at GenSpera, Inc.. Join LinkedIn today for free. See who you know at GenSpera, Inc., leverage your professional network, and get hired.

scr.zacks.com/News/Press-Releases/Press-Release-Details/2016/NSPX-GenSpera-Changes-Name-to-Inspyr-Therapeutics-Focused-on-Development-of-Mipsagargin-for-Multiple-Cancer-Indications-article/default.aspx

Aug 19, 2016 ... Inspyr Therapeutics, Inc. (OTC:NSPX) is a biotechnology company focused on the targeted delivery of a novel anti-cancer agent specifically to cancerous tissue, thus mitigating systemic adverse effects that are typical with standard chemotherapeutic agents. The novel cytotoxic therapeutic agent is ...

www.itnonline.com/company/genspera-inc

GenSpera Inc. 2511 N. Loop 1604 W., Ste. 204. San Antonio, TX 78258. USA. Phone: 210.479.8112. Cdionne@genspera.com (link sends e-mail) · www. genspera.com. Product Categories: Clinical Study, PET Imaging, Radiopharmaceuticals and Tracers, SPECT Imaging, Nuclear Imaging ...

www.xconomy.com/texas/2016/08/04/inspyr-formerly-genspera-replaces-co-founder-dionne-with-new-ceo

Aug 4, 2016 ... San Antonio---Inspyr Therapeutics, a biotech company based in San Antonio formerly known as GenSpera, has hired Christopher Lowe as its new CEO and preside. ... He registered a new company, CDionne Inc., with the Texas Secretary of State in May. Inspyr declined to comment beyond a news release ...

seekingalpha.com/article/3245765-genspera-and-cancer-specific-hand-grenades

Jun 10, 2015 ... ... not being fully appreciated, offering an investor the potential for significant gains. By Jason Napodano, CFA & David Bautz, PhD. We are initiating coverage of GenSpera, Inc. (OTCQB:GNSZ) with a Buy rating and a $1.25 price target. GenSpera is a pharmaceutical company focused on the development of.

twitter.com/gensperanews?lang=en

The latest Tweets from GenSpera, Inc. (@GenSperaNews). GenSpera, Inc. ( OTCQB: $GNSZ) is a development stage oncology company focused on therapeutics that deliver a potent, unique & patented drug directly to tumors. San Antonio, TX.